These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23940901)

  • 1. The North Carolina Controlled Substances Reporting System: a valuable tool for combating prescription drug misuse.
    Bronson WD
    N C Med J; 2013; 74(3):249-53. PubMed ID: 23940901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minnesota's Prescription Monitoring Program: how to identify patients who may be abusing controlled substances.
    Carter BA; Wiberg C
    Minn Med; 2011 Oct; 94(10):55-6. PubMed ID: 23256287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription drug diversion: a law enforcement perspective.
    Varnell DR
    N C Med J; 2013; 74(3):246. PubMed ID: 23940900
    [No Abstract]   [Full Text] [Related]  

  • 4. A New Paradigm for Providers: Dentists and Pharmacists.
    Park T
    J Calif Dent Assoc; 2015 Nov; 43(11):669-71. PubMed ID: 26798884
    [No Abstract]   [Full Text] [Related]  

  • 5. The Minnesota Prescription Monitoring Program.
    Herman C
    Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopping doctor-shoppers.
    Bell H
    Minn Med; 2013 Mar; 96(3):16-9. PubMed ID: 23930462
    [No Abstract]   [Full Text] [Related]  

  • 7. Using Prescription Drug Monitoring Programs to Address Drug Abuse.
    Hansen M
    NCSL Legisbrief; 2015 Mar; 23(12):1-2. PubMed ID: 26173300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
    Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP
    BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MSD guidelines for the use of controlled substances for the treatment of pain.
    Medical Society of Delaware
    Del Med J; 2013 Apr; 85(4):115-21. PubMed ID: 23767250
    [No Abstract]   [Full Text] [Related]  

  • 10. Corneal abrasions and controlled substances.
    Brockman TA
    J Okla State Med Assoc; 2014 Jul; 107(7):374-5. PubMed ID: 25223150
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription drug overdose and misuse: data from Carolinas Poison Center.
    Ford M; Dulaney AR
    N C Med J; 2013; 74(3):244. PubMed ID: 23940899
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription Drug Monitoring Program.
    CDA Practice Support
    J Calif Dent Assoc; 2014 Jul; 42(7):482-3. PubMed ID: 25076632
    [No Abstract]   [Full Text] [Related]  

  • 13. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final Notice.
    N Y State Dent J; 2016 Jan; 82(1):15-6. PubMed ID: 26939151
    [No Abstract]   [Full Text] [Related]  

  • 15. CME: Arkansas Prescription Drug Monitoring Program: informing physicians how to use new monitoring tool.
    Penn CL
    J Ark Med Soc; 2013 Jul; 110(1):18-9. PubMed ID: 24228352
    [No Abstract]   [Full Text] [Related]  

  • 16. Finding a feasible solution. States employ different legislative strategies to curb misuse.
    Milhofer J
    Minn Med; 2013 Mar; 96(3):52-4. PubMed ID: 23930472
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug Monitoring Programs Help Patients and Dentists.
    TDIC Risk Management Staff
    J Calif Dent Assoc; 2015 Nov; 43(11):679-80. PubMed ID: 26798886
    [No Abstract]   [Full Text] [Related]  

  • 18. The supply chain of medicinal controlled substances: addressing the Achilles heel of drug diversion.
    Coleman JJ
    J Pain Palliat Care Pharmacother; 2012 Sep; 26(3):233-50. PubMed ID: 22973912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription-type drug misuse and workplace access among nurses.
    Trinkoff AM; Storr CL; Wall MP
    J Addict Dis; 1999; 18(1):9-17. PubMed ID: 10234559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.